| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ZELTIQ AESTHETICS INCORPORATED | 2,603,528 | 83,391,000 | 14.66% | ||
| 2 | AIMMUNE THERAPEUTICS INC COM | 2,820,000 | 71,402,000 | 12.55% | ||
| 3 | CEMPRA INC | 2,193,060 | 61,055,000 | 10.73% | ||
| 4 | LOXO ONCOLOGY INC COM | 3,452,493 | 60,350,000 | 10.61% | ||
| 5 | Esperion Therapeutics Inc | 1,637,125 | 38,620,000 | 6.79% | ||
| 6 | ADMA BIOLOGICS, INC. | 3,608,171 | 30,164,000 | 5.30% | ||
| 7 | CHIMERIX INC | 722,943 | 27,616,000 | 4.85% | ||
| 8 | VERSARTIS INC COM | 2,279,568 | 26,283,000 | 4.62% | ||
| 9 | DERMIRA INC | 1,102,046 | 25,722,000 | 4.52% | ||
| 10 | T2 BIOSYSTEMS INC | 2,523,300 | 22,104,000 | 3.89% | ||
| 11 | Agile Therapeutics, Inc. | 2,983,797 | 20,111,000 | 3.54% | ||
| 12 | TRANSENTERIX INC | 8,335,819 | 18,839,000 | 3.31% | ||
| 13 | CATALENT INC | 715,673 | 17,391,000 | 3.06% | ||
| 14 | CYNAPSUS THERAPEUTICS INC | 975,191 | 15,769,000 | 2.77% | ||
| 15 | PARATEK PHARMACEUTICALS INC | 682,680 | 12,971,000 | 2.28% | ||
| 16 | CIDARA THERAPEUTICS INC | 1,019,458 | 12,967,000 | 2.28% | ||
| 17 | Intersect ENT Inc | 350,000 | 8,190,000 | 1.44% | ||
| 18 | PERNIX THERAPEUTICS HLDGS IN | 2,010,000 | 6,352,000 | 1.12% | ||
| 19 | LOMBARD MEDICAL INC | 886,363 | 3,164,000 | 0.56% | ||
| 20 | SORRENTO THERAPEUTICS INC COM NEW | 353,855 | 2,969,000 | 0.52% | ||
| 21 | PERNIX THERAPEUTICS HLDGS IN | 2,500,000 | 1,809,000 | 0.32% | PRN | |
| 22 | ROKA BIOSCIENCE INC | 811,886 | 1,583,000 | 0.28% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-15-002414, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
